FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385835258> ?p ?o ?g. }

• W4385835258 endingPage "69" @default.
• W4385835258 startingPage "55" @default.
• W4385835258 abstract "BACKGROUND: Cervical cancers (CaCx), like many other cancer types, portray high molecular heterogeneity that affects response to therapy, including immunotherapy. In India and other developing countries, CaCx mortality rates are very high because women report to the clinics with advanced cancers in absence of organized screening programs. This calls for implementation of newer therapeutic regimens for CaCx, like immunotherapy, which is again not used commonly in such countries. OBJECTIVE: Therefore, we focused on dissecting tumour immune heterogeneity, if any, identify immune gene-based biomarkers of heterogeneity and subsets of such cancers with the potential for immunotherapy. We also attempted to characterize the cancer-associated phenotypes of such subsets, including viral load, to decipher the relationship of tumour immunogenicity with oncogenicity. METHODS: Employing RNA-seq analysis of 44 HPV16 positive CaCx patients, immune subtypes were identified by unsupervised hierarchical clustering of global immune-gene expression profiles. Proportions of tumor infiltrating immune cells in the tumor milieu were estimated, employing Cell-type Identification by Estimating Relative Subsets of RNA Transcripts (CIBERSORT), using gene expression data from RNA-seq. The oncogenic phenotypes of the immune subtypes of CaCx were deciphered through differential gene expression (DEGs) and pathway enrichment analysis. Viral load was estimated through TaqMan-based qRT-PCR analysis. RESULTS: Analysis revealed the presence of two immune subtypes of CaCx, A (26/44; 59.09%) and B (18/44; 40.90%). Compared to Subtype-A, Subtype-B portrayed overexpression of immune genes and high infiltration of immune cells, specifically CD8+ T cells (p < 0.0001). Besides, a significant correlation between PD-1 and PD-L1 co-expression among Subtype-B, as opposed to Subtype-A, confirmed the interactive roles of these immune checkpoint molecules in Subtype B. Stepwise discriminant analysis pin-pointed ten immune-genes that could classify 100% of the patients significantly (p < 0.0001) into the two immune subtypes and serve as potential biomarkers of CaCx immunity. Differential gene expression analysis between the subtypes unveiled that Subtype-B was more biologically aggressive than Subtype-A, reflecting loss of structural integrity and promotion of cancer progression. The viral load was significantly lower in Subtype-B (average viral load = 10.74/100 ng of genomic DNA) compared to Subtype-A (average viral load = 14.29/100 ng of genomic DNA). Thus viral load and the ten-gene panel underscore their association with immunogenicity and oncogenicity. CONCLUSION: Our study provides strong evidence that only a subset, about 41% of HPV16 positive CaCx patients in India, portray immune enrichment of the tumor milieu coupled with aggressive phenotypes. Such subtypes are therefore likely to benefit through checkpoint molecule-based or tumor infiltrating lymphocyte-based immunotherapy, which could be a leap forward in tackling aggressive forms of such CaCx in India and other developing countries." @default.
• W4385835258 created "2023-08-16" @default.
• W4385835258 creator A5034782324 @default.
• W4385835258 creator A5044913071 @default.
• W4385835258 creator A5048721124 @default.
• W4385835258 creator A5054935353 @default.
• W4385835258 creator A5056137797 @default.
• W4385835258 creator A5063942147 @default.
• W4385835258 creator A5072953177 @default.
• W4385835258 creator A5074656484 @default.
• W4385835258 creator A5084339682 @default.
• W4385835258 creator A5087671724 @default.
• W4385835258 date "2023-08-14" @default.
• W4385835258 modified "2023-10-14" @default.
• W4385835258 title "Identification of HPV16 positive cervical cancer subsets characterized by divergent immune and oncogenic phenotypes with potential implications for immunotherapy" @default.
• W4385835258 cites W1529926831 @default.
• W4385835258 cites W1978663073 @default.
• W4385835258 cites W1985987855 @default.
• W4385835258 cites W1998743183 @default.
• W4385835258 cites W2006019758 @default.
• W4385835258 cites W2007917102 @default.
• W4385835258 cites W2060945630 @default.
• W4385835258 cites W2070371366 @default.
• W4385835258 cites W2079664362 @default.
• W4385835258 cites W2093901599 @default.
• W4385835258 cites W2132412086 @default.
• W4385835258 cites W2152820745 @default.
• W4385835258 cites W2159650706 @default.
• W4385835258 cites W2179438025 @default.
• W4385835258 cites W2229135620 @default.
• W4385835258 cites W2413997174 @default.
• W4385835258 cites W2752117457 @default.
• W4385835258 cites W2766016099 @default.
• W4385835258 cites W2899148072 @default.
• W4385835258 cites W2899250708 @default.
• W4385835258 cites W2923032339 @default.
• W4385835258 cites W2925815206 @default.
• W4385835258 cites W2939144109 @default.
• W4385835258 cites W2943793962 @default.
• W4385835258 cites W2944461151 @default.
• W4385835258 cites W2966041852 @default.
• W4385835258 cites W2981675070 @default.
• W4385835258 cites W2992830842 @default.
• W4385835258 cites W2995567198 @default.
• W4385835258 cites W2999403235 @default.
• W4385835258 cites W3080630050 @default.
• W4385835258 cites W3084314351 @default.
• W4385835258 cites W3086666947 @default.
• W4385835258 cites W3096656318 @default.
• W4385835258 cites W3123308657 @default.
• W4385835258 cites W3128646645 @default.
• W4385835258 cites W3131164337 @default.
• W4385835258 cites W3133603350 @default.
• W4385835258 cites W3134580165 @default.
• W4385835258 cites W3156172967 @default.
• W4385835258 cites W3156577277 @default.
• W4385835258 cites W3164142437 @default.
• W4385835258 cites W3165677144 @default.
• W4385835258 cites W3189007213 @default.
• W4385835258 cites W3197597161 @default.
• W4385835258 cites W3204381417 @default.
• W4385835258 cites W3205812700 @default.
• W4385835258 cites W3207068799 @default.
• W4385835258 cites W3209125666 @default.
• W4385835258 cites W4221039219 @default.
• W4385835258 cites W4281644132 @default.
• W4385835258 cites W4281856638 @default.
• W4385835258 cites W4283762291 @default.
• W4385835258 cites W4285012094 @default.
• W4385835258 cites W4293510921 @default.
• W4385835258 cites W4298008695 @default.
• W4385835258 doi "https://doi.org/10.3233/tub-220035" @default.
• W4385835258 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37599552" @default.
• W4385835258 hasPublicationYear "2023" @default.
• W4385835258 type Work @default.
• W4385835258 citedByCount "0" @default.
• W4385835258 crossrefType "journal-article" @default.
• W4385835258 hasAuthorship W4385835258A5034782324 @default.
• W4385835258 hasAuthorship W4385835258A5044913071 @default.
• W4385835258 hasAuthorship W4385835258A5048721124 @default.
• W4385835258 hasAuthorship W4385835258A5054935353 @default.
• W4385835258 hasAuthorship W4385835258A5056137797 @default.
• W4385835258 hasAuthorship W4385835258A5063942147 @default.
• W4385835258 hasAuthorship W4385835258A5072953177 @default.
• W4385835258 hasAuthorship W4385835258A5074656484 @default.
• W4385835258 hasAuthorship W4385835258A5084339682 @default.
• W4385835258 hasAuthorship W4385835258A5087671724 @default.
• W4385835258 hasBestOaLocation W43858352581 @default.
• W4385835258 hasConcept C104317684 @default.
• W4385835258 hasConcept C121608353 @default.
• W4385835258 hasConcept C127716648 @default.
• W4385835258 hasConcept C167672396 @default.
• W4385835258 hasConcept C203014093 @default.
• W4385835258 hasConcept C2777701055 @default.
• W4385835258 hasConcept C2780674031 @default.
• W4385835258 hasConcept C2780868878 @default.
• W4385835258 hasConcept C502942594 @default.
• W4385835258 hasConcept C54355233 @default.

• next